A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Recruiting now
Conditions studied: Cystic Fibrosis
In brief
The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to inform CF research, help design CF clinical trials and support the development of new treatments for people with CF who do not take CFTR modulators. Another goal of this study is to learn about research involvement for people with CF who do not take CFTR modulators, engage them in research, and give them an opportunity to learn about what is involved in participating in a CF research study.
Key facts
- Study ID
- NCT06504589
- Run by
- Nicole Hamblett
- People needed
- 400
- Starts
- 2024-09-18
- Expected to finish
- 2029-08-14
- Last updated by the study team
- 2025-10-01
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Children's Hospital Alabama, University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
- Boston Children's Hospital — Boston, Massachusetts, United States (enrolling)
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States (enrolling)
- Phoenix Children's Hospital — Phoenix, Arizona, United States (enrolling)
- Tucson Cystic Fibrosis Center — Tucson, Arizona, United States (enrolling)
- Stanford University Medical Center — Palo Alto, California, United States (enrolling)
- University of California, San Francisco - Adult Center — San Francisco, California, United States (enrolling)
- University of California, San Francisco - Peds Center — San Francisco, California, United States (enrolling)
- Children's Hospital Colorado — Aurora, Colorado, United States (enrolling)
- National Jewish Health — Denver, Colorado, United States (enrolling)
- Childrens Hospital Los Angeles — Los Angeles, California, United States (enrolling)
- University of Miami — Miami, Florida, United States (enrolling)
- Central Florida Pulmonary Group — Orlando, Florida, United States (enrolling)
- Tampa General Hospital — Tampa, Florida, United States (enrolling)
- Children's Healthcare of Atlanta and Emory University — Atlanta, Georgia, United States (enrolling)
- Augusta University — Augusta, Georgia, United States (enrolling)
- Saint Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho, United States (enrolling)
- Northwestern University — Chicago, Illinois, United States (enrolling)
- Riley Hospital for Children — Indianapolis, Indiana, United States (enrolling)
- University of Kansas Medical Center — Kansas City, Kansas, United States (enrolling)
- University of Kentucky — Lexington, Kentucky, United States (enrolling)
- Tulane University — Metairie, Louisiana, United States (enrolling)
- University of Florida — Gainesville, Florida, United States (enrolling)
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
- University of Massachusetts Memorial Health Care — Worcester, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.